Norepinephrine 8 mg per in 0 recalled over sterility concerns
- Recall date
- July 7, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SterRx, LLC recalls Norepinephrine 8 mg per 250 mL (32 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12…
- Recall number
- D-0932-2023
- FDA classification
- Class II
- Brand / firm
- SterRx, LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Norepinephrine 8 mg per 250 mL (32 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-577-01.
Get recall alerts
Free email alert whenever SterRx, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SterRx, LLC